The Myriad model is based on 7,461 samples tested for BRCA1/2 mutations and 2,539 samples of detected mutations in three descendants of Ashkenazi Jewish ancestry (including FH, age of onset of FBOC, and presence of invasive cancer) to establish a model to predict the possibility of carrying mutations. This evidence concerns the gene BRCA1 and familial hyperaldosteronism.